Clincosm LogoSign in Get a demo

Choroidal Thickness Association With Primary Angle Closure

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03050073
Collaborator
(none)
42
Enrollment
1
Location
8.4
Actual Duration (Months)
5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A chinese study shows that chinese population eyes with a primary angle closure have a greater choroidal thickness than normal eyes.The increase of choroidal thickness would be associated to this primary angle closure.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Usual ophtalmic consultation for glaucoma with primary angle closure

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    42 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Choroidal Thickness Association With Primary Angle Closure
    Actual Study Start Date :
    Apr 18, 2016
    Actual Primary Completion Date :
    Jun 30, 2016
    Actual Study Completion Date :
    Dec 31, 2016

    Outcome Measures

    Primary Outcome Measures

    1. change of choroidal thickness measurement by Imaging of the fundus oculi (OCT swept source) [Day 1 Day 30]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Age >18 years

    • Primary angle closure confirmed by gonioscopy

    • interpretable images for choroidal thickness measure

    • interpretable images by Ultra Bio Microscopy (UBM)

    Exclusion Criteria:

    • Acute crisis for angle closure

    • Rethinopathy (diabetic or hypertensive)

    • Histories of intra-eye surgery

    • Great myopia

    • Hypermetropia

    • retinal pathology

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Study Director: Hélène BEAUSSIER, Pharm-D, CRC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT03050073
    Other Study ID Numbers:
    • IRIS
    First Posted:
    Feb 10, 2017
    Last Update Posted:
    Aug 10, 2018
    Last Verified:
    Aug 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 10, 2018